Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with
hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching …

Background: Lichen planopilaris (LPP) is a primary chronic lymphocytic cutaneous disorder
that selectively destroys the hair follicles, resulting in scarring alopecia. Unfortunately …

Methotrexate (MTX) is a readily accessible drug, first used in 1948 and employed for a wide
variety of indications since then. However, despite widespread off‐label use, FDA labeling …

Oral lichen planus (OLP), a T-lymphocyte-mediated disease of the oral mucosa, has a
complex pathogenesis that involves a number of factors. The disease is characterized by …

Background. Lichen planopilaris (LPP) is a rare inflammatory disorder of the scalp that
causes cicatricial alopecia. No therapeutic approach has been approved for this disease …

Primary cicatricial alopecia can result in permanent hair loss from the destruction of hair
follicles. Early intervention is key in controlling disease progression, reducing symptoms …

Lichen planopilaris (LPP) is a scarring alopecia for which no treatment with remarkable
effect has been identified. Pioglitazone has been reported as a possible therapeutic option …

Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are primary, lymphocytic
cicatricial hair loss disorders. These model epithelial stem cell (SC) diseases are thought to …

Introduction: Lichen planopilaris (LPP) is a common type of primary cicatricial alopecia.
Previous studies focused on the epidemiology, clinical characteristics, and treatment of LPP …

Background. Lichen planopilaris is the leading cause of cicatricial alopecia, and its
management is challenging for dermatologists. It is a cell‐mediated autoimmune disorder in …